Reductions in symptom distress reported by patients with moderately severe, nonerosive gastroesophageal reflux disease treated with rabeprazole.

This publication has 12 references indexed in Scilit:

• Rabeprazole in nonerosive gastroesophageal reflux disease: a randomized placebo-controlled trial
  American Journal of Gastroenterology, 2002
• Measuring symptom distress and health-related quality of life in clinical trials of gastroesophageal reflux disease treatment: further validation of the Gastroesophageal Reflux Disease Symptom Assessment Scale (GSAS).
  Digestive Diseases and Sciences, 2002
• Quality of life in patients with endoscopy-negative heartburn: reliability and sensitivity of disease-specific instruments
  American Journal of Gastroenterology, 2001
• Effectiveness and Costs of Omeprazole vs Ranitidine for Treatment of Symptomatic Gastroesophageal Reflux Disease in Primary Care Clinics in West Virginia
  Archives of Family Medicine, 2000
• The Impact of Gastroesophageal Reflux Disease on Health-related Quality of Life 11Supported by research funding from Astra/Merck, Wayne, Pennsylvania.
  The American Journal of Medicine, 1998
• Treating the symptoms of gastro‐oesophageal reflux disease: a double‐blind comparison of omeprazole and cisapride
  Alimentary Pharmacology & Therapeutics, 1997
• Reliability and validity of the gastrointestinal symptom rating scale in patients with gastroesophageal reflux disease
  Quality of Life Research, 1997
• Gastroesophageal reflux disease.
  1996
• Methodological aspects of evaluation of Quality of Life in upper gastrointestinal diseases.
  1993
• Healing and relapse of severe peptic esophagitis after treatment with omeprazole
  Gastroenterology, 1988